(Q41712922)

English

Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.

scientific article published on January 1998

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

review article

1 reference

stated in

Europe PubMed Central

title

Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1

C D Marsden

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7 October 2017

C D Marsden

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

publication date

1 January 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

volume

55 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

page(s)

17-22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9483166

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9483166%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

cites work

Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9483166

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9483166

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9483166

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q41712922)

Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)